BPX-601
BPX-601-PSA-2540
Phase 1 gene_therapy active
Quick answer
BPX-601 for Prostate Cancer is a Phase 1 program (gene_therapy) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Prostate Cancer
- Phase
- Phase 1
- Modality
- gene_therapy
- Status
- active